oasis 1 trial oral semaglutide 50 mg obesity nejm 2023 Most viewed this week from JAMA Internal Medicine: of # daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or # New NEJM Trials: Oral GLP-1

For wrist injuries with skin involvement or surgical incisions, adding GHK-Cu may accelerate surface healing while BPC-157 addresses deeper structures

Given its simultaneous gut repair and neuroprotective effects, BPC-157 may offer a novel approach to conditions where gut dysbiosis and neurological symptoms intersect, including certain anxiety disorders and depression

Challenges, Side Effects, and Cost Gastrointestinal symptoms like nausea and diarrhea are common with GLP1 therapies, including oral versions

Rambhia subsequently completed her internship at The Mount Sinai Hospital and her dermatology residency at Zucker School of Medicine/Northwell Health, where she was selected as Chief Resident in her final year